Markedly reduced skeletal muscle oxidative capacity with elevated circulating GDF-15 in children with cerebral palsy

Abstract Background Cerebral palsy (CP) is associated with progressive skeletal muscle weakness and reduced physical capacity, yet the contribution of mitochondrial dysfunction to these impairments remains incompletely understood. Methods We therefore evaluated skeletal muscle mitochondrial health in children with CP and typically developing (TD) children (12.9±3.4years) using a comprehensive approach integrating high-resolution respirometry, targeted protein analyses, circulating biomarkers, and plasma proteomics. Thirty-six skeletal muscle biopsies from 22 children with CP, and 15 muscle biopsies from TD children were collected during planned orthopedic surgery. Results Skeletal muscle from children with CP exhibited markedly reduced oxidative capacity (−50% in CP vs TD, p <0.001), accompanied by broad reductions in mitochondrial and substrate transport proteins suggesting reduced mitochondrial content. Despite the absence of local or systemic inflammation, circulating growth differentiation factor-15 (GDF-15), a biomarker of mitochondrial distress, was elevated in children with CP (337±53 vs 626±547pg·ml −1 for TD vs CP, p <0.05) and was highest among those with more severe motor impairments. Conclusion These findings demonstrate that previously reported reductions in skeletal muscle mitochondrial protein content in CP translate into profound impairments in mitochondrial function. Moreover, the dissociation between mitochondrial dysfunction and inflammatory signaling suggests that mitochondrial insufficiency in CP occurs independently of inflammation. Elevated circulating GDF-15 further suggests that mitochondrial dysfunction in CP may extend beyond skeletal muscle and exert systemic effects. Together, our findings identify mitochondrial insufficiency as a prominent feature of skeletal muscle pathology in CP potentially acting as a contributor to secondary health complications across the lifespan

Authors

Institutions

Publication Details

Journal
Molecular Medicine
Published
2026-11-17
DOI
https://doi.org/10.1186/s10020-026-01700-4
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Markedly reduced skeletal muscle oxidative capacity with elevated circulating GDF-15 in children with cerebral palsy

Johanna T. Lanner, Julia Röja, Linnéa Corell, William Apró et al.
1 links
Molecular Medicine
Muscle Physiology and Disorders
article

Markedly reduced skeletal muscle oxidative capacity with elevated circulating GDF-15 in children with cerebral palsy

Johanna T. Lanner, Julia Röja, Linnéa Corell, William Apró, Oscar Horwath, Evgenia Manousaki, Ferdinand von Walden, Eva Pontén, Filip Jon Larsen, Sebastian Edman, Rebekah Ding Jin, Baptiste Jude
article en

Abstract

Abstract Background Cerebral palsy (CP) is associated with progressive skeletal muscle weakness and reduced physical capacity, yet the contribution of mitochondrial dysfunction to these impairments remains incompletely understood. Methods We therefore evaluated skeletal muscle mitochondrial health in children with CP and typically developing (TD) children (12.9±3.4years) using a comprehensive approach integrating high-resolution respirometry, targeted protein analyses, circulating biomarkers, and plasma proteomics. Thirty-six skeletal muscle biopsies from 22 children with CP, and 15 muscle biopsies from TD children were collected during planned orthopedic surgery. Results Skeletal muscle from children with CP exhibited markedly reduced oxidative capacity (−50% in CP vs TD, p <0.001), accompanied by broad reductions in mitochondrial and substrate transport proteins suggesting reduced mitochondrial content. Despite the absence of local or systemic inflammation, circulating growth differentiation factor-15 (GDF-15), a biomarker of mitochondrial distress, was elevated in children with CP (337±53 vs 626±547pg·ml −1 for TD vs CP, p <0.05) and was highest among those with more severe motor impairments. Conclusion These findings demonstrate that previously reported reductions in skeletal muscle mitochondrial protein content in CP translate into profound impairments in mitochondrial function. Moreover, the dissociation between mitochondrial dysfunction and inflammatory signaling suggests that mitochondrial insufficiency in CP occurs independently of inflammation. Elevated circulating GDF-15 further suggests that mitochondrial dysfunction in CP may extend beyond skeletal muscle and exert systemic effects. Together, our findings identify mitochondrial insufficiency as a prominent feature of skeletal muscle pathology in CP potentially acting as a contributor to secondary health complications across the lifespan

Molecular Medicine
Karolinska University Hospital (SE), Karolinska Institutet (SE), Swedish School of Sport and Health Sciences (SE)
Karolinska Institutet
Good health and well-being
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon